Scilex Holding (SCLXW) Total Liabilities (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Total Liabilities of $547.7 million in Q1 2026, down 5.03% quarter-over-quarter from $576.7 million in Q4 2025, and up 88.56% on a YoY basis from $290.5 million in Q1 2025.

Scilex Holding (SCLXW) Total Liabilities (2020 - 2026) Analysis & Trends

Scilex Holding's Total Liabilities history runs 7 years deep, the most recent figure standing at $547.7 million for Q1 2026.

  • In Q1 2026, Total Liabilities rose 88.56% year-over-year to $547.7 million; the TTM figure through Mar 2026 stood at $547.7 million (up 88.56% YoY), while the FY2025 annual figure was $576.7 million, up 101.94% from the prior year.
  • Total Liabilities was $547.7 million for Q1 2026 at Scilex Holding, down from $576.7 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $576.7 million in Q4 2025 to a low of $11.1 million in Q1 2022.
  • Historically, Total Liabilities has averaged $249.2 million across 5 years, with a median of $281.0 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Total Liabilities slumped 83.34% in 2022, then soared 1898.54% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $50.3 million in 2022, then soared by 445.35% to $274.2 million in 2023, then gained by 4.14% to $285.6 million in 2024, then soared by 101.94% to $576.7 million in 2025, then fell by 5.03% to $547.7 million in 2026.
  • The last three Total Liabilities figures came in at $547.7 million (Q1 2026), $576.7 million (Q4 2025), and $455.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -61.27 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 85.38 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 119.71 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 143.08 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 82.75 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 83.31 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 32.76 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 117.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 66.37 Bn
10 Scilex Holding - - 4.15 Mn 547.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 547.71 Mn
Dec 31, 2025 576.73 Mn
Sep 30, 2025 455.60 Mn
Jun 30, 2025 332.74 Mn
Mar 31, 2025 290.46 Mn
Dec 31, 2024 285.59 Mn
Sep 30, 2024 311.75 Mn
Jun 30, 2024 319.24 Mn
Mar 31, 2024 281.03 Mn
Dec 31, 2023 274.25 Mn
Sep 30, 2023 243.20 Mn
Jun 30, 2023 116.05 Mn
Mar 31, 2023 74.98 Mn
Dec 31, 2022 50.29 Mn
Sep 30, 2022 12.17 Mn
Jun 30, 2022 52.88 Mn
Mar 31, 2022 11.10 Mn
Dec 31, 2021 301.81 Mn
Sep 30, 2021 10.09 Mn
Jun 30, 2021 8.90 Mn